Simulations Plus (SLP) EBITDA Margin (2010 - 2026)

Simulations Plus (SLP) reported EBITDA Margin of 20.56% for Q2 2026, up 38507.0% on a YoY basis from N/an in Q2 2025, and down 11.31% sequentially from 23.18% in Q1 2026.

Simulations Plus (SLP) EBITDA Margin (2010 - 2026) Analysis & Trends

Simulations Plus (SLP) has 17 years of EBITDA Margin data on file, last reported at 20.56% in Q2 2026.

  • For the quarter ending Q2 2026, EBITDA Margin rose 38507.0% year-over-year to 20.56%; the trailing twelve-month figure through May 2026 stood at 14.02% (up 10426.0% YoY), and the FY2025 full-year result was 89.33%, down 9808.0% from the prior year.
  • EBITDA Margin retreated to 20.56% in Q2 2026, from 23.18% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 37.04% in Q1 2022 to a low of 364.51% in Q2 2025.
  • A 5-year average of 7.4% and a median of 8.74% in 2022 frame the typical range for EBITDA Margin.
  • Across the five-year window, EBITDA Margin plunged 37465 bps in 2025 and soared 38507 bps in 2026, its largest moves.
  • Tracing SLP's EBITDA Margin over 5 years: stood at 7.34% in 2022, then dropped by 10 bps to 6.62% in 2023, then plunged by 90 bps to 0.67% in 2024, then soared by 481 bps to 3.87% in 2025, then soared by 431 bps to 20.56% in 2026.
  • Business Quant data shows SLP's EBITDA Margin at 20.56% in Q2 2026, 23.18% in Q1 2026, and 3.87% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Veeva Systems 33.04 Bn 25.73 Bn 662.02 Mn 30.93%
2 Healthequity 8.57 Bn 8.30 Bn 256.31 Mn 29.03%
3 10x Genomics 5.94 Bn 5.40 Bn 106.18 Mn -11.30%
4 Hinge Health 5.91 Bn 5.59 Bn 154.23 Mn 17.59%
5 MiniMed 4.63 Bn 4.33 Bn 480.00 Mn -11.11%
6 Waystar Holding 4.61 Bn 4.55 Bn 216.84 Mn 25.64%
7 Doximity 4.02 Bn 3.27 Bn 125.97 Mn 17.08%
8 Privia Health 3.09 Bn 2.67 Bn - 1.23%
9 Omnicell 1.94 Bn 1.70 Bn 140.36 Mn 5.44%
10 Simulations Plus 371.24 Mn 321.25 Mn 15.13 Mn 20.56%

Historic Data

Download Data
DateValue
May 31, 2026 20.56%
Feb 28, 2026 23.18%
Nov 30, 2025 3.87%
Aug 31, 2025 3.77%
May 31, 2025 -364.51%
Feb 28, 2025 12.09%
Nov 30, 2024 0.67%
Aug 31, 2024 -6.17%
May 31, 2024 10.14%
Feb 29, 2024 24.27%
Nov 30, 2023 6.62%
Aug 31, 2023 -1.82%
May 31, 2023 25.24%
Feb 28, 2023 25.61%
Nov 30, 2022 7.34%
Aug 31, 2022 5.91%
May 31, 2022 33.06%
Feb 28, 2022 37.04%
Nov 30, 2021 30.53%
Aug 31, 2021 1.77%